MARKET

ABCL

ABCL

Abcellera Biologics Inc.
NASDAQ
11.17
+0.28
+2.57%
After Hours: 11.21 +0.04 +0.36% 19:58 09/14 EDT
OPEN
10.66
PREV CLOSE
10.89
HIGH
11.31
LOW
10.66
VOLUME
4.45M
TURNOVER
--
52 WEEK HIGH
12.58
52 WEEK LOW
2.745
MARKET CAP
3.62B
P/E (TTM)
-20.5067
1D
5D
1M
3M
1Y
5Y
1D
FDA names acting heads of drug and vaccine units to permanent roles
Seeking Alpha · 6d ago
Weekly Report: what happened at ABCL last week (0831-0904)?
Weekly Report · 09/07 09:07
Analysts Offer Insights on Healthcare Companies: TransMedics Group (TMDX), Medtronic (MDT) and AbCellera Biologics (ABCL)
TipRanks · 09/02 11:30
Mid-cap healthcare stocks ranked by quant ratings after earnings season
Seeking Alpha · 09/01 14:15
Weekly Report: what happened at ABCL last week (0824-0828)?
Weekly Report · 08/31 09:08
What'sGoing On With AbCellera Biologics Stock On Tuesday?
Benzinga · 08/25 18:38
HHS said to be eyeing two new FDA deputy commissioners for technology and drugs
Seeking Alpha · 08/25 17:53
AbCellera rises 10.7%
TipRanks · 08/25 14:06
More
About ABCL
AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas, including cancer, metabolic and endocrine conditions, and autoimmune disorders. Its platform integrates technology, data science, infrastructure, and interdisciplinary teams to solve the challenging antibody discovery problems. It is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two internal programs, ABCL635 and ABCL575, are in late-preclinical studies. ABCL635 is an antibody drug candidate for metabolic and endocrine conditions, and ABCL575 is an antibody drug candidate with broad potential in inflammatory conditions and autoimmune diseases and an initial indication in atopic dermatitis. ABCL575 binds OX40L to disrupt OX40/OX40L signaling, a regulator of inflammatory pathways in AD. In addition to ABCL635 and ABCL575, it is advancing a pipeline of more than 20 internal discovery programs.

Webull offers AbCellera Biologics Inc stock information, including NASDAQ: ABCL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABCL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABCL stock methods without spending real money on the virtual paper trading platform.